8.3 Psychiatric and Mental Health Nursing

8.3 Psychiatric and Mental Health Nursing

Psychiatric and mental health nursing requires an advanced synthesis of interpersonal communication theories, neurobiological sciences, psychopharmacological surveillance, and rigorous clinical risk triage. Registered nurses must maintain therapeutic boundaries, de-escalate behavioral crises, evaluate suicide lethality, and manage complex psychiatric medication emergencies such as Serotonin Syndrome, Lithium Toxicity, and Neuroleptic Malignant Syndrome.

---

Therapeutic Communication & Interpersonal Boundaries

Therapeutic communication is an intentional, patient-centered interpersonal process designed to facilitate expression of feelings, cultivate insight, and foster adaptive behavioral change while establishing firm professional boundaries.

Core Therapeutic Techniques

• Open-Ended Questions: Encourage broad, descriptive responses that explore thoughts and emotional states without directing the answer (e.g., "What was that experience like for you?" or "How have you been feeling since that occurred?").
• Active Listening (SOLER Framework): Demonstrates complete physical and emotional presence: Sit squarely facing the patient, Observe an open posture (uncrossed arms/legs), Lean slightly forward toward the patient, Establish appropriate eye contact, and Relax.
• Broad Openings: Allow the patient to take the initiative in introducing the conversation topic (e.g., "Where would you like to begin today?" or "What is on your mind this morning?").
• Reflection: Directs questions, feelings, and ideas back to the patient, encouraging them to recognize their own emotional reality (e.g., Patient: "My family never visits; they don't care about me." Nurse: "You feel that your family has abandoned you?").
• Restatement / Paraphrasing: Repeats the main thought the patient expressed in similar or fewer words to confirm mutual clarity and signal that the nurse is actively following the thought process.
• Exploring: Delves deeper into a specific feeling or topic without being intrusive or interrogative (e.g., "Tell me more about what happens right before you feel that panic.").
• Offering Self: Makes the nurse's physical and emotional presence available to the patient unconditionally, without demands (e.g., "I notice you are having a difficult morning; I will sit here with you for 15 minutes.").
• Strategic Silence: Allows quiet intervals for the patient to gather emotional thoughts, process difficult disclosures, and take the initiative to speak.
• Validating Feelings: Acknowledges the patient's emotional distress without judging or minimizing (e.g., "It must feel exhausting and frightening to carry so much distress.").

Non-Therapeutic Communication Barriers (What to Avoid)

Exam questions frequently present clinical dialogues where the nurse must identify non-therapeutic barriers:

---

Suicide Risk Assessment, Triage & Inpatient Safety Protocols

Suicide risk assessment is a core clinical competency requiring direct, unapologetic clinical inquiry, objective stratification of lethality, and continuous protective environmental safeguards.

Comprehensive Suicide Assessment Framework

• The SAD PERSONS Scale: A validated clinical mnemonic scoring tool evaluating static and dynamic risk factors:
  • Sex: Male (higher completion rate by 3-4x due to violent means; females attempt more frequently).
  • Age: < 19 years or > 65 years (highest completion rate in elderly men > 75).
  • Depression / Hopelessness: Hopelessness is the single strongest psychological predictor of suicide.
  • Previous Suicide Attempt: The single greatest overall predictor of completed suicide.
  • Ethanol / Substance Abuse: Disinhibits behavioral impulses and increases lethal actions.
  • Rational Thinking Loss: Psychosis, command auditory hallucinations instructing self-harm.
  • Social Support Deficit: Living alone, isolated, lack of family or community ties.
  • Organized Plan: Detailed method, timeframe, and designated location.
  • No Spouse: Divorced, separated, widowed, or single.
  • Sickness: Chronic, debilitating, painful medical illness (cancer, renal failure, chronic pain).

Direct Inquiry Protocol

A persistent clinical myth is that asking patients about suicide will "plant the thought" in their minds. Scientific evidence conclusively demonstrates that direct inquiry relieves isolation and reduces suicide risk. Nurses must ask direct, unambiguous questions in a calm, matter-of-fact tone:

1. Ideation: "Are you having thoughts of hurting yourself or wanting to die?"
2. Intent: "Do you intend to act on those thoughts?"
3. Specific Plan: "Do you have a specific plan of how you would end your life?"
4. Lethality & Access to Means: "Do you have access to the means (firearm, prescription medications, rope) to carry out that plan?"

The Paradoxical Warning Sign

One of the most dangerous, deceptive clinical presentations occurs when a patient with severe, chronic Major Depressive Disorder who has been withdrawn, tearful, and vegetative suddenly exhibits a dramatic, unexpected elevation in mood, cheerful affect, and a sudden surge of physical energy. This abrupt change does not indicate clinical recovery from depression (antidepressants take weeks to work). Instead, it is an ominous red flag signaling that the patient has resolved their painful internal ambivalence by finalizing the decision to complete suicide! The decision brings immense emotional relief from chronic suffering, and the surge in energy provides the physical capacity to execute the lethal plan. The nurse must immediately intervene, place the patient on 1-to-1 constant observation, and reassess for imminent suicide plans.

Inpatient Suicide Safety & Environmental Precautions

• Observation Levels:
  • One-to-One (1:1) Constant Observation: Uninterrupted visual contact 24 hours a day, maintaining the patient within arm's length at all times, including during bathroom use, showering, and sleeping. Indicated for imminent intent, acute command hallucinations, or active suicide plans.
  • Line-of-Sight Observation: Continuous direct visual observation from a short distance.
  • 15-Minute Checks: Unpredictable, irregular checks every 15 minutes for stabilized patients.
• Environmental Contraband Sweep: Remove all potential ligature points (anchors capable of supporting weight), electrical cords, cell phone chargers, call bells, shoelaces, belts, ties, brassiere underwires, plastic trash bags, glass mirrors, and sharp items.
• Mealtime Precautions: Serve meals using only plastic utensils and paper/foam plates. The nurse must count and reconcile all utensils before the tray is delivered and immediately after the tray is retrieved.
• Medication Cheeking Checks: Directly inspect the oral cavity ("mouth check" under tongue, inside cheeks, and posterior pharynx) following every oral medication administration to prevent hoarding for a lethal overdose.

Major Depressive Disorder (MDD) & Antidepressant Pharmacotherapy

Major Depressive Disorder is a disabling mood disorder characterized by persistent neurochemical dysregulation within serotonergic, noradrenergic, and dopaminergic neural circuits.

Diagnostic Hallmarks (DSM-5)

Diagnosis requires at least two consecutive weeks of persistently depressed mood or anhedonia (inability to experience pleasure in previously enjoyed activities), accompanied by at least four additional SIGECAPS symptoms:

• Sleep disturbance (insomnia or hypersomnia)
• Interest diminished (anhedonia)
• Guilt excessive or feelings of worthlessness
• Energy loss or chronic fatigue
• Concentration impairment or indecisiveness
• Appetite / weight alterations (> 5% change in body weight in a month)
• Psychomotor agitation or severe retardation
• Suicidal ideation or recurrent thoughts of death

Selective Serotonin Reuptake Inhibitors (SSRIs)

• Medications: Fluoxetine, Sertraline, Citalopram, Escitalopram, Paroxetine.
• Mechanism: Selectively block the presynaptic serotonin transporter (SERT), inhibiting serotonin reuptake and increasing 5-HT availability in synaptic clefts.
• Patient Education & Onset: Therapeutic clinical response requires 2 to 4 weeks (and up to 6 to 8 weeks for maximal efficacy). Patients must be educated not to discontinue the medication prematurely. Common early side effects (nausea, headache, insomnia) typically subside within 1 to 2 weeks, while sexual dysfunction (anorgasmia, delayed ejaculation, decreased libido) may persist.
• Black-Box Warning: Increased risk of emergent suicidal thoughts and behaviors in children, adolescents, and young adults (up to age 24) during the initial 1 to 4 weeks of therapy or following dose titrations. Enhanced surveillance is mandatory.

Serotonin Syndrome (Serotonergic Toxicity)

Serotonin syndrome is an acute, life-threatening hyper-serotonergic crisis resulting from excessive stimulation of central and peripheral $5-HT_{1A}$ and $5-HT_{2A}$ receptors, triggered by combining SSRIs, SNRIs, tricyclic antidepressants, MAOIs, triptans, tramadol, linezolid, dextromethorphan, or the herbal supplement St. John's Wort.

Serotonin Syndrome Clinical Triad:
1. MENTAL STATUS CHANGES: Agitation, restlessness, delirium, confusion.
2. AUTONOMIC INSTABILITY: Diaphoresis, hyperthermia (>38-40°C), tachycardia, labile BP.
3. NEUROMUSCULAR HYPERACTIVITY: Hyperreflexia, spontaneous/inducible CLONUS, tremors.

• Clinical Presentation:
  • Mental Status Changes: Agitation, anxiety, delirium, disorientation, combativeness.
  • Autonomic Hyperactivity: Profuse diaphoresis, severe tachycardia, fluctuating blood pressure, tachypnea, hyperthermia (can exceed 40°C in severe cases), mydriasis (dilated pupils), hyperactive bowel sounds with watery diarrhea.
  • Neuromuscular Abnormalities: Hyperreflexia (exaggerated deep tendon reflexes, especially in lower extremities), spontaneous or inducible ankle clonus (rhythmic calf/foot oscillations), tremors, shivering, and bilateral muscle rigidity.
• Emergency Nursing Interventions:
  1. Immediately discontinue all serotonergic medications STAT.
  2. Administer IV fluids for hydration and cooling.
  3. Administer IV Benzodiazepines (Lorazepam 1-2 mg) to control agitation, reduce muscle hypertonicity, and suppress seizure activity.
  4. Apply active external cooling blankets for hyperthermia.
  5. In moderate-to-severe cases, administer the specific serotonin antagonist Cyproheptadine (first-line oral $5-HT_{2A}$ receptor blocker).
• Mandatory MAOI Washout Period: To prevent fatal serotonin syndrome, a strict 14-day washout period is mandatory between discontinuing an SSRI and initiating an MAOI (Phenelzine, Tranylcypromine, Isocarboxazid, Selegiline). For Fluoxetine, a 5-week washout period is strictly required due to the prolonged elimination half-life of its active metabolite, norfluoxetine.

---

Bipolar Disorder, Acute Mania & Lithium Carbonate Management

Bipolar I Disorder is characterized by at least one manic episode consisting of an abnormally and persistently elevated, expansive, or irritable mood accompanied by abnormally increased goal-directed activity.

Clinical Presentation of Acute Mania (DIG FAST)

• Distractibility (inability to focus)
• Indiscretion / Impulsivity (reckless spending, hypersexuality, poor judgment)
• Grandiosity (inflated self-esteem, delusions of fame/power)
• Flight of ideas / Racing thoughts
• Activity increased (psychomotor agitation, multiple unfinished projects)
• Sleep deficit (decreased need for sleep, feeling fully rested after 1-2 hours)
• Talkativeness (loud, intrusive, pressured speech)

Inpatient Nursing Interventions for Acute Mania

1. Low-Stimulation Milieu: Provide a quiet private room away from high-traffic zones and nursing stations. Dim room lights, keep ambient noise low, and limit interpersonal group interactions to prevent escalating sensory overstimulation.
2. High-Calorie, High-Protein Finger Foods: Manic patients continuously pace and cannot sit still for seated dining. Provide portable, nutrient-dense finger foods: peanut butter sandwiches, cheese sticks, hard-boiled eggs, chicken nuggets, sliced fruit, and high-protein nutrition shakes. Provide frequent sips of water to prevent severe dehydration.
3. Behavioral Limit-Setting: Establish firm, clear, consistent boundaries delivered in a calm, non-judgmental, matter-of-fact tone. Avoid debating, bargaining, or arguing with grandiosity. Redirect frantic physical energy into structured, solitary gross-motor activities (walking, folding towels).

Lithium Carbonate: Therapeutic Index & Toxicity Management

Lithium carbonate remains the gold-standard mood stabilizer for acute bipolar mania and long-term recurrence prevention. It possesses an extraordinarily narrow therapeutic index:

Lithium Carbonate Therapeutic Monitoring Windows:
- Acute Mania Target Level: 0.8 to 1.2 mEq/L
- Maintenance Target Level: 0.6 to 1.0 mEq/L
- Toxic Serum Concentration: > 1.5 mEq/L

Lithium Toxicity Staging & Clinical Hallmarks

• Mild Toxicity (1.5 to 2.0 mEq/L): Worsening fine hand tremors transitioning into a coarse hand tremor, persistent nausea, vomiting, severe watery diarrhea, lethargy, muscle weakness, and hyperactive deep tendon reflexes.
• Moderate Toxicity (2.0 to 2.5 mEq/L): Marked ataxia (unsteady, staggering gait), profound lethargy, slurred speech, blurred vision, tinnitus, clonic muscle twitching, and acute confusion.
• Severe Toxicity (> 2.5 mEq/L): Generalized seizures, stupor, coma, complex cardiac dysrhythmias, hypotension, peripheral vascular collapse, oliguria, acute renal failure, and death.
• Emergency Interventions: Discontinue lithium immediately; obtain stat lithium level, electrolytes, BUN, creatinine, and 12-lead ECG; infuse aggressive IV 0.9% Normal Saline to promote renal lithium excretion; prepare for Emergent Hemodialysis (indicated for lithium levels > 2.5 mEq/L, or > 2.0 mEq/L with severe neurologic compromise or acute renal failure).

Fluid, Sodium & Drug Interactions: Critical Patient Teaching

Lithium is a monovalent inorganic cation filtered by the glomeruli and reabsorbed in the renal proximal convoluted tubules identically to sodium:

• The Sodium-Lithium Interplay: When the body is sodium-depleted (hyponatremia) or dehydrated, the proximal tubules compensatory increase the reabsorption of sodium. In doing so, the kidneys simultaneously reabsorb lithium, causing rapid toxic lithium accumulation!
• Dietary Sodium & Fluid Instructions: Instruct the patient to maintain a consistent daily fluid intake of 2 to 3 liters (2,000 to 3,000 mL/day) and maintain a consistent, normal dietary sodium intake. Patients must NEVER adopt a low-sodium diet, crash diet, or drastically alter salt intake without medical consultation.
• Dangerous Drug Interactions:
  1. Diuretics (Especially Thiazides like Hydrochlorothiazide): Excrete sodium in the distal tubule, triggering massive proximal tubular reabsorption of lithium and precipitating acute, severe lithium toxicity. (Loop diuretics also carry high risk).
  2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Ibuprofen, naproxen, celecoxib inhibit renal prostaglandins, decreasing glomerular filtration and reducing lithium clearance, raising serum lithium levels by 30% to 50%. Safe alternative for analgesia: Acetaminophen or Aspirin.
  3. ACE Inhibitors and ARBs (Lisinopril, Losartan): Reduce glomerular filtration rate and dramatically elevate lithium levels.
• Routine Laboratory Surveillance: Serum lithium trough levels must be drawn 12 hours post-dose (in the morning prior to the first daily dose). Baseline and periodic (every 6 to 12 months) evaluation of Renal Function (BUN, Creatinine) (risk of nephrogenic diabetes insipidus and chronic tubulointerstitial nephritis) and Thyroid Function (TSH, Free T4) (lithium inhibits thyroid hormone synthesis, causing goiter and primary hypothyroidism).

---

Schizophrenia Spectrum Disorders & Antipsychotic Therapeutics

Schizophrenia is a chronic psychiatric syndrome characterized by profound disturbances in thought processes, perception, emotional regulation, and interpersonal functioning.

Positive vs. Negative Symptoms

• Positive Symptoms (Mesolimbic Dopaminergic Hyperactivity): Reflect an excess or distortion of normal cognitive functions:
  • Hallucinations: Sensory perceptions without external stimuli. Auditory hallucinations are most common (hearing voices). Command hallucinations (voices instructing self-harm or violence toward others) represent a psychiatric emergency.
  • Delusions: Fixed, false personal beliefs refractory to logical evidence (persecutory/paranoid, grandiose, ideas of reference [believing television broadcasts contain secret personal messages], somatic, control).
  • Disorganized Thinking & Speech: Loose associations (illogical jumps between unrelated topics), neologisms (invented meaningless words), clang associations (rhyming words), word salad (incoherent mixture of words).
  • Grossly Disorganized or Catatonic Behavior: Bizarre posturing, waxy flexibility, catatonic stupor, or extreme purposeless agitation.
• Negative Symptoms (Mesocortical Dopaminergic Hypoactivity): Reflect a reduction or loss of normal functions (The "5 As"):
  • Affective flattening (restricted facial expressions, monotone voice)
  • Alogia (poverty of speech, laconic replies)
  • Avolition (lack of motivation, severe apathy, inability to complete tasks)
  • Anhedonia (inability to experience pleasure)
  • Asociality (severe social withdrawal and disinterest in relationships)
  • Clinical Distinction: Negative symptoms account for profound long-term social disability and are notoriously resistant to first-generation typical antipsychotics.

Therapeutic Nursing Communication for Psychosis

• Responding to Hallucinations:
  1. Inquire directly regarding the content: "What are the voices saying to you? Are they telling you to hurt yourself or anyone else?" (screens for command intent).
  2. Validate the emotional feeling without validating the false perception: "I can see that hearing those voices is very frightening and distressing for you."
  3. Clarify reality gently: "I do not hear the voices, but I believe that they are real to you."
  4. Do not argue, debate, or challenge ("The voices aren't real, you are imagining them" increases paranoia); never validate false perceptions ("What are the voices angry about?" reinforces psychosis).
  5. Re-orient to the present environment and engage the patient in reality-based activities (music, puzzles, simple tasks).
• Responding to Delusions:
  1. Acknowledge the underlying feeling: "It must feel terrifying to believe that government agents are watching you."
  2. Avoid arguing or attempting to logically disprove the delusion ("That is impossible; there are no cameras here").
  3. Do not validate or delve into delusional details; gently cast doubt: "I understand that feels real to you, but I find it hard to believe the hospital staff wants to harm you. You are safe here."
  4. Focus the conversation on real-world topics, feelings, and concrete activities.

Antipsychotic Pharmacology: Adverse Effect Profiles

Antipsychotic Adverse Effect Stratification:
- Typical Agents (Haloperidol): High D2 blockade -> High EPS, Tardive Dyskinesia, NMS.
- Atypical Agents (Olanzapine, Quetiapine): 5-HT2A/D2 blockade -> High Metabolic Syndrome.
- Clozapine (Atypical): Risk of Fatal AGRANULOCYTOSIS -> Mandatory ANC Monitoring.

1. Extrapyramidal Symptoms (EPS) (Predominant in Typical FGAs - Haloperidol, Fluphenazine)

• Acute Dystonia (Hours to Days): Severe, agonizing, spastic involuntary contractions of muscle groups. Presents as torticollis (twisted neck), trismus (jaw spasm), oculogyric crisis (involuntary, sustained upward deviation of the eyes), and laryngeal dystonia (airway emergency). Treatment: Immediate administration of IM or IV Anticholinergics: Benztropine (Cogentin 1 to 2 mg) or Diphenhydramine (Benadryl 25 to 50 mg). Symptoms resolve within minutes.
• Akathisia (Days to Weeks): Intense, intolerable subjective motor restlessness and inner tension. Manifests as inability to sit still, continuous pacing, rocking back and forth, and shifting weight between feet. Treatment: Lipophilic beta-blockers (Propranolol), benzodiazepines (Lorazepam), or dosage reduction.
• Pseudoparkinsonism (Weeks to Months): Bradykinesia, mask-like blank facial expression, resting "pill-rolling" hand tremor, cogwheel muscle rigidity, and a slow, shuffling gait. Treatment: Oral anticholinergics (Benztropine) or the dopamine agonist Amantadine.
• Tardive Dyskinesia (TD) (Months to Years): Late-onset, potentially irreversible syndrome of involuntary, choreoathetoid movements of the tongue, lips, face, and trunk: tongue protrusion ("flycatcher tongue"), lip smacking, chewing movements, facial grimacing, and choreic movements of extremities. Screening: Periodic examination with the Abnormal Involuntary Movement Scale (AIMS). Management: Discontinue or taper the offending agent; switch to an atypical with minimal D2 affinity (Clozapine or Quetiapine). Administer VMAT2 inhibitors (Valbenazine, Deutetrabenazine). CRITICAL PHARMACOLOGICAL RULE: Anticholinergics (Benztropine) do NOT treat Tardive Dyskinesia and will exacerbate TD symptoms!

2. Neuroleptic Malignant Syndrome (NMS)

Neuroleptic Malignant Syndrome is a rare, idiosyncratic, life-threatening emergency caused by acute central dopamine receptor blockade:

• Clinical Tetrad:
  1. Severe "Lead-Pipe" Muscle Rigidity: Generalized, uniform resistance across all extremities during passive movement.
  2. Extreme Hyperthermia: Core body temperature escalating rapidly to > 38.0°C to > 40.0°C (100.4°F to 104°F).
  3. Autonomic Instability: Severe sinus tachycardia, labile/fluctuating blood pressure, profuse diaphoresis, tachypnea, cardiac dysrhythmias.
  4. Altered Mental Status: Fluctuating from confusion, agitation, and catatonic mutism to stupor and coma.
• Diagnostic Laboratory Profile: Massive elevation of serum Creatine Kinase (CPK > 1,000 to 10,000+ U/L) from acute rhabdomyolysis, marked leukocytosis (WBC 15,000 to 30,000/mm³), elevated serum transaminases, and myoglobinuria.
• Emergency Nursing Interventions:
  1. Immediately discontinue all antipsychotic medications STAT.
  2. Transfer patient to the Intensive Care Unit.
  3. Initiate aggressive external core cooling (cooling blankets, ice packs to axillae/groin).
  4. Infuse aggressive IV crystalloids to expand intravascular volume and prevent myoglobinuric acute renal failure.
  5. Administer the direct skeletal muscle relaxant IV Dantrolene Sodium and/or dopamine agonists (Bromocriptine mesylate, Amantadine) to reverse central dopaminergic blockade.

3. Second-Generation Atypical Antipsychotics & The Clozapine Protocol

• Atypical Agents: Olanzapine, Risperidone, Quetiapine, Aripiprazole, Ziprasidone, Clozapine.
• Mechanism & Benefits: Dual serotonin ($5-HT_{2A}$) and dopamine ($D_2$) antagonism; low risk of EPS and tardive dyskinesia; effective for both positive and negative symptoms.
• Metabolic Syndrome Hazard: Second-generation agents carry high risks of significant weight gain, hyperlipidemia, and new-onset Type 2 diabetes mellitus (highest risk with Olanzapine and Clozapine; lowest risk with Aripiprazole and Ziprasidone). Requires baseline and routine monitoring of BMI, waist circumference, fasting lipid panels, and fasting blood glucose / HbA1c.
• The Clozapine Protocol & Agranulocytosis Mandate:
  • Clinical Indication: Indicated exclusively for severe, treatment-resistant schizophrenia (failure of at least two prior antipsychotic trials) or persistent recurrent suicidal behavior in schizophrenia.
  • Black-Box Hazard: Agranulocytosis (severe, potentially fatal depletion of absolute neutrophils, leaving the patient completely vulnerable to fulminant sepsis).
  • Mandatory Blood Monitoring: Participation in the mandatory Clozapine REMS monitoring registry. Baseline Absolute Neutrophil Count (ANC) must be >= 1,500/mm³ (>= 1,000/mm³ for Benign Ethnic Neutropenia [BEN]) prior to treatment initiation. ANC is monitored weekly for the first 6 months, biweekly for months 6 to 12, and monthly thereafter for the duration of therapy.
  • Emergency Action Threshold: If the Absolute Neutrophil Count drops below 1,000/mm³ (or < 500/mm³ in BEN), the nurse must IMMEDIATELY WITHHOLD CLOZAPINE, notify the psychiatrist STAT, place the patient in reverse protective isolation, and monitor for infection!
  • Patient Teaching: Instruct the patient to immediately report any early signs of infection: fever, shivering chills, sore throat, painful swallowing, mouth ulcers, or profound malaise. Other serious black-box risks of clozapine include myocarditis, cardiomyopathy, severe gastrointestinal hypomotility (toxic megacolon), and dose-dependent seizures.